Spotting ovarian cancer, before it's too late

by Mark Riechers
Credit: Normal (left) and cancerous (right) cells.

(Medical Xpress)—At just 28 percent, the five-year survival rate for women diagnosed with ovarian cancer is much lower than in other cancer cases. And, the disease can easily go unnoticed, making it difficult to find effective treatments. "There are very few symptoms associated with ovarian cancer," says Biomedical Engineering Associate Professor Paul Campagnola. "When it gets detected, it's usually too late."

While his colleagues work to find the most efficient therapies for patients in the later stages of the disease, Campagnola and his students are using more nuanced analysis of tissue imaging to diagnose ovarian and earlier. Understanding what tissue changes preclude the development of certain cancers could help doctors diagnose eariler and give patients a wider window in which to seek treatment. "We're trying to develop a physical and biochemical understanding of the changes that happen as cancer develops," says Campagnola.

The key lies in understanding the (ECM), the tissue made up of collagen and elastin that essentially holds the body together. The ECM supports all organs, including the skin. "It's increasingly recognized that there are changes in the collagen—particularly in the extracellular matrix—that accompany almost all cancers," says Campagnola. "Almost all cancers are epithelial—that's the top layer of cells—but they interact with the tissue below it."

Modeling how cancers can dictate the types and concentration of different collagens in the ECM nearby, Campagnola hopes to identify less common "collagen isoforms" as markers that could be used to screen women at risk for ovarian cancer regularly, improving their odds of an early diagnosis.

Campagnola and his students are developing a combination of optics and imaging techniques that could improve the odds an ovarian has at survival. And they are imaging different mixtures of known collagen types with a variety of techniques to see if they can differentiate between normal and abnormal ECM structure. That, says Campagnola, is key to an accurate diagnosis.

add to favorites email to friend print save as pdf

Related Stories

Role of known cancer gene in ovarian cancer investigated

Feb 14, 2012

The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia ...

Potential for earlier diagnosis of ovarian cancer

Jan 25, 2012

(Medical Xpress) -- Australian scientists have identified biochemical changes that commonly occur in the DNA of women with ovarian cancer, which may help diagnose the cancer at an earlier stage in the future.

Recommended for you

Clearing cells to prevent cervical cancer

12 hours ago

A study published online in the International Journal of Cancer earlier this month describes a novel approach to preventing cervical cancer based on findings showing successful reduction in the risk of cervical cancer after ...

Is Europe putting cancer research at risk?

16 hours ago

The European Society for Medical Oncology (ESMO), the leading pan-European association representing medical oncology professionals, has expressed concern that the proposed EU General Data Protection Regulation could make ...

User comments